K2 Therapeutics raises $50.0M Seed (Singapore, Aug 2026)
Find the investors funding Health Seed rounds
326,000+ verified VCs, angels and family offices — direct emails, check sizes and stage filters.
Singapore-based biotech K2 Therapeutics secures US$50 million seed round; appoints Huang Ying as CEO - The Business Times
K2 Therapeutics is a Singapore-based biotech company focused on developing innovative therapies. The company has recently secured a significant seed funding round to advance its research and development efforts. This funding will support their mission to create impactful solutions in the healthcare sector.
Singapore-based biotech K2 Therapeutics secures US$50 million seed round; appoints Huang Ying as CEO The Business Times
| Sep 03, 2026 | Laters.com | $1.5M | Seed | Singapore |
| Aug 31, 2026 | Singapore | $173.0M | — | Singapore |
| Aug 31, 2026 | Singapore Fintech | $173.0M | — | Singapore |
| Aug 31, 2026 | Monetary Authority of Singapore | $165.0M | Grant | Singapore |
12,490 investors back startups in Singapore
You just read who funded K2 Therapeutics. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.